Skip to main content

Therapeutic Areas

Infectious Disease Testing and Monitoring


Viracor has extensive experience performing pathogen load monitoring, antiviral resistance assessment, nucleic acid sequencing and other pathogen characterizations for clinical trials.

With a wide range of viral and bacterial targets, you have access to a comprehensive menu of real-time PCR and sequencing assays for pathogen detection and monitoring. Viracor’s multiple-target, dual gene assays, an approach we adopted early in the transition to molecular diagnostics, are designed to eliminate false negative results or under-quantification.


As experts in infectious disease assays, we offer a broad array of testing solutions for biomarker detection, immunogenicity, and other safety and efficacy assessments to support anti-viral and vaccine candidate clinical programs. 

We also offer validated molecular and serology tests for SARS-CoV-2, along and other bioassay solutions that are helping our clients COVID-19 vaccine and anti-viral therapy development efforts.


Viracor offers clients a wealth of infectious disease testing options for clinical studies, including:

  • Custom development, validation and optimization of qPCR and genotyping assays for wide range of pathogens
  • Multiple-target, dual gene assays, designed to eliminate risk of false negatives or under-quantified viral loads.
  • Wide array of specimen types validated, and rapid TAT


Additional Chronic Viral Infection Testing:

  • Human Immunodeficiency virus (HIV)
  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Human T-lymphotropic virus (HTLV)
  • Cytomegalovirus (CMV)
  • Epstein-Barr virus (EBV)
  • Adenovirus (ADV)
  • Human herpesvirus (HHV-6, HHV-7, HHV-8)
  • BK virus (BKV)
  • John Cunningham (JC) virus
Back to top